- Supported exchanges /
- NSE /
- IPCALAB.NSE
IPCA Laboratories Limited (IPCALAB NSE) stock market data APIs
Ipca Laboratories Limited, a pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company also provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, hematology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. It also exports its products worldwide. The company was incorporated in 1949 and is based in Mumbai, India.
IPCA Laboratories Limited Financial Data Overview
1607.15 | |
1600.55 | |
- | |
1621.8 | |
1595.25 | |
1039.3779-1708.65 | |
407 740 M | |
65.5712 | |
254 M | |
82 133 M | |
9.05 | |
0.0026 | |
0.229 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
IPCA Laboratories Limited Fundamental Data is available in our Financial Data APIs
- Net Revenue 82 133 M
- EBITDA 13 422 M
- Earnings Per Share 24.51
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get IPCA Laboratories Limited Earnings via APIs
- Latest Release 2024-11-08
- EPS/Forecast 9.0867
Get IPCA Laboratories Limited End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: